Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Other neoplasm 3Myeloid 3Lymphoid 2Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 115Myelodysplastic Syndromes 107Leukemia 98Leukemia, Myeloid, Acute 92Anemia 70Leukemia, Myelomonocytic, Chronic 68Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Myeloproliferative Disorders 55Leukemia, Lymphocytic, Chronic, B-Cell 52Multiple Myeloma 48Anemia, Refractory 48Thrombocytopenia 45Lymphoma 43Lymphoma, Non-Hodgkin 42Neoplasms 40Hodgkin Disease 39Primary Myelofibrosis 36Leukemia, Myeloid, Chronic-Phase 36Congenital Abnormalities 34Anemia, Aplastic 34Myelodysplastic-Myeloproliferative Diseases 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33Leukemia, Myeloid, Accelerated Phase 32Lymphoma, Follicular 29Blast Crisis 27Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 26Burkitt Lymphoma 25Lymphoma, Mantle-Cell 24Neoplasms, Plasma Cell 23Lymphoma, B-Cell, Marginal Zone 23

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Preleukemia × Classical hematology × Clear all
NCT04741945 2024-11-22

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Rigshospitalet, Denmark

Phase 2 Recruiting
40 enrolled
Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡